Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 101–150 of 751 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04013854	Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab	active not recruiting	Phase 2	67	Abramson Cancer Center at Penn MedicineOTHER	1	Sep 4, 2026	clinicaltrials
NCT07287917	Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	92	Aminex Therapeutics, Inc.INDUSTRY	1	Sep 4, 2026	clinicaltrials